Who
John G. Cooper
Director
Company insider
Files Form 4 as: Director, Rockwell Medical; President & CEO, Windtree Therapeutics.
In numbers
- Trades disclosed
- 86
- Buys
- 2
- Sells
- 1
- Bought
- $38K
- Sold
- $4,419
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 21 Jul 2005
- Last trade
- 1 Jul 2026
- Last filed
- 6 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —9,633 at $0.00 | filing |
| 1 Jul 2026filed 6 Jul 2026 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —9,633 at $0.00 | filing |
| 18 Nov 2025filed 18 Nov 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Sold | $4,4195,079 at $0.87 | filing |
| 20 May 2025filed 21 May 2025 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —36,111 at $0.00 | filing |
| 23 May 2023filed 25 May 2023 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —24,715 at $0.00 | filing |
| 7 Jun 2022filed 9 Jun 2022 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 17 Jun 2021filed 22 Jun 2021 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —72,857 at $0.00 | filing |
| 17 Jun 2021filed 22 Jun 2021 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 18 May 2020filed 20 May 2020 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —34,024 at $0.00 | filing |
| 18 May 2020filed 20 May 2020 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —36,000 at $0.00 | filing |
| 6 Jun 2019filed 10 Jun 2019 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —22,461 at $0.00 | filing |
| 6 Jun 2019filed 10 Jun 2019 | RMTI Rockwell MedicalBiotechnology | SEC FORM 4 Code A | —19,879 at $0.00 | filing |
| 19 Mar 2018filed 21 Mar 2018 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —39,838 at $0.00 | filing |
| 5 Sep 2017filed 8 Sep 2017 | RMTI Rockwell Medicaloption or derivative · Biotechnology | SEC FORM 4 Code A | —23,000 at $0.00 | filing |
| 22 Jul 2015filed 24 Jul 2015 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Bought | —41,667 | filing |
| 22 Jul 2015filed 24 Jul 2015 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code P | —41,667 | filing |
| 30 Jun 2015filed 24 Jul 2015 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $3,3764,964 at $0.68 | filing |
| 31 Mar 2015filed 24 Jul 2015 | Windtree TherapeuticsBiotechnology | SEC FORM 4 Code A | $3,3752,836 at $1.19 | filing |
| 27 Mar 2015filed 31 Mar 2015 | Windtree Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —97,437 at $0.00 | filing |
News
Rockwell Medical (NASDAQ:RMTI) Shares Cross Above Two Hundred Day Moving Average After Analyst DowngradeRMTI · tickerreport.com · 17 Oct 2026
0 headlines in the last 90 days name John G. Cooper; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.